- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Mar 31, 2026 | 205.22M sh |
| Shares Outstanding | Q1 2026 · Dec 31, 2025 | 203.77M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $75M |
| Capex | Q1 2026 · Mar 31, 2025 | $56M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $401M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $95M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $8.5B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $7.9B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $325M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $231M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $5.5B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.81B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $5.42B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $5.56B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $955M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.02B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $11.36B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $10.74B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.06B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.15B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $16.93B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.66B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $14.65B |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $11M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $10M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$163M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$3M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $20M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $0 |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $134M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $122M |